Brian Blakey
Corporate Officer/Principal bei STEALTH BIOTHERAPEUTICS CORP
Aktive Positionen von Brian Blakey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Corporate Officer/Principal | 01.02.2014 | - |
Stealth BioTherapeutics, Inc.
 Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Corporate Officer/Principal | 01.02.2014 | - |
Karriereverlauf von Brian Blakey
Ehemalige bekannte Positionen von Brian Blakey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Ogilvy Commonhealth Market Access
 Ogilvy Commonhealth Market Access Advertising/Marketing ServicesCommercial Services Part of WPP Plc, Ogilvy Commonhealth Market Access is a company that provides medical marketing services. The company is based in Newtown, CT. Ogilvy Commonhealth Market Access was acquired by Ogilvy Commonhealth Worldwide LLC on October 07, 2014. | Geschäftsführer | 01.06.2010 | 01.02.2014 |
| Corporate Officer/Principal | 01.06.2010 | 01.02.2014 | |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Corporate Officer/Principal | 01.05.2006 | 01.05.2010 |
| GSK PLC | Direktor/Vorstandsmitglied | 01.07.2003 | 01.02.2004 |
Ausbildung von Brian Blakey
| University of Florida | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Ogilvy Commonhealth Market Access
Ogilvy Commonhealth Market Access Advertising/Marketing ServicesCommercial Services Part of WPP Plc, Ogilvy Commonhealth Market Access is a company that provides medical marketing services. The company is based in Newtown, CT. Ogilvy Commonhealth Market Access was acquired by Ogilvy Commonhealth Worldwide LLC on October 07, 2014. | Commercial Services |
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Needham, MA. | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Health Technology |
- Börse
- Insiders
- Brian Blakey
- Erfahrung